CEVIMELINE
NDC 69452-316, CEVIMELINE HYDROCHLORIDE, capsule, from Bionpharma Inc.
- Product NDC
- 69452-316
- Status
- Listed
- Labeler
- Bionpharma Inc
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218290
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69452-316 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CEVIMELINE HYDROCHLORIDE30 mg/1
Pharmacologic classes
Cholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69452-316-20 | 69452031620 | 100 CAPSULE in 1 BOTTLE (69452-316-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0f15cb50-5917-c928-e063-6294a90ab284NADAC price for package 69452031620
GET /v1/drugs/nadac/69452031620
Use it
Look up 69452-316 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69452-316 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69452-316. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.